DiaMedica Therapeutics director and exec each buys $150K in common stock

In regulatory filing, DiaMedica Therapeutics disclosed that its director Richard Pilnik and Chief Business Officer David Wambeke each bought 38.36K shares of common stock on June 23rd in a total transaction size of $150K for each person.